Advances neuroprotective small-molecule therapies to preserve neuronal integrity and stop disease progression.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Nura Bio develops neuroprotective therapies designed to prevent axon degeneration and treat complex neurological disorders. The organization focuses on targeting fundamental metabolic pathways and neuroimmune regulatory mechanisms to preserve neuronal integrity. Through its integrated drug discovery engine, the enterprise works to advance small-molecule candidates toward clinical applications to halt disease progression.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Nura Bio Management Team
Investors
Column Group
Euclidean Capital
Samsara BioCapital
Sanofi Ventures
Nura Bio Valuations & Financials
View real-time NPM data on Nura Bio stock including daily Nura Bio stock price estimates, valuation history, and historical share price information. Access Nura Bio financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Nura Bio pricing across six independent market signals. Looking for private company due diligence data sources on Nura Bio? Get in touch to learn more.
Similar Companies
like Nura Bio
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
FluidStack
AI & Machine Learning
Cloud platform providing scalable GPU infrastructure for AI workloads by aggregating underutilized data center resources at competitive rates.
Everysk
FinTech
Connect financial systems and streamline data, analytics, and compliance processes.
OneSkin
Healthcare & Life Sciences
Transforming how skincare works by harnessing a senescence-targeting peptide that rejuvenates skin at the cellular level.
Anonyome Labs
Cybersecurity
Empowers individuals and businesses to control and protect personal information with privacy, cyber safety, and identity protection solutions.
TinyFish
AI & Machine Learning
Innovator that automates high-value workflows using adaptive agents for seamless, scaled web interaction.
Undefeated
Consumer
Specializes in premium streetwear, sneakers, and exclusive collaborations with top fashion and sportswear brands.
Collaborative Drug Discovery
Healthcare & Life Sciences
Facilitates secure management and collaboration of scientific data for drug discovery, enhancing productivity and protecting intellectual property.
Destinus
Industrials
Delivers hydrogen‑powered high‑speed vehicles to transform long‑distance travel and transport.
FAQ
We have answers
Nura Bio stock does not trade on public stock exchanges. Nura Bio stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Nura Bio stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Nura Bio Stock does not trade on public stock exchanges. In order to sell Nura Bio shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Nura Bio does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Nura Bio share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Nura Bio stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Nura Bio stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Nura Bio stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Nura Bio is a private company and has not had an IPO. There is currently no Nura Bio IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Nura Bio IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
